Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,581.3
-14.7 (-0.56%)

 

  • STI Straits Times Index
    2,581.3
    -14.7 (-0.56%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,564.6
    -11.8 (-0.75%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,183.0
    -47.7 (-0.19%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,360.1
    39.4 (1.19%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,289.4
    39.8 (0.17%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,247.7
    8.4 (0.16%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,818.9M
  • Value: 1,195.1M
  • Rise: 145
  • Fall: 205
  • Unch: 458

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.036-
Yinda Infocomm0.035-
Rex Intl0.168-0.013
ChinaKundaTech0.028+0.002
FJ Benjamin^0.020+0.002
Singapore-eDev0.062-0.012
Medtecs Intl1.610+0.050
ThaiBev0.605-
Kitchen Culture0.215-0.105
AnAn Intl0.037-

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,246.6 -303.4
HSCEI 9,742.1 -111.1
Jakarta 4,863.1 -41.0
Nikkei 225 22,062.1 -450.0
SSE Comp 2,958.7 -11.9
Shanghai A 3,101.3 -12.4
Shanghai B 211.6 -1.8
KOSPI 2,098.0 -36.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

AMGEN-T AMGEN-T
Quotes 15 Minutes Delayed. Updated at 14 Aug 2020 09:00
Last (HKD): 1,000.000 Change: - High: 1,000.000 Remarks: -
Change (%): - Low: 1,000.000
Open 1,000.000 Yesterday's Close 1000.000
Buy Price 400.000 Sell Price -
Buy Volume ('000) 0.31 Sell Volume ('000) -
Cumulative Volume ('000) - Cumulative Value -
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 104.90738 Trailing EPS (HKD) e 97.13688 NAV (HKD) b 141.0498
PE a 9.532 Trailing PE f 10.295 Price / NAV b 7.0897
Dividend (HKD) d 45.886880 Cash In Hand (HKD) g 121.0152 Issued & Paid-up Shares c 585,694,000
Dividend Yield (%) d 4.589 Price / Cash In Hand g 8.263 Treasury Shares h -
Beta - 75 Daysi - R-Squared - 75 Days(%)i - Market Cap (M) 585,694.000
Beta - 500 Daysi - R-Squared - 500 Days (%)i - Enterprise Value (M) 762,427.512
Piotroski F Score 6 Exchange Code 4332 Par Value ( USD ) 0.00010
52 Weeks Volatility (%) - 6-Month VWAP n.a. Free Float (%) 99.8
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 30 Jul 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 17 Sep 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Industry Biotechnology HKEx 60,331.380 22.556 26.316 6.6519 2.221
Local Peer WUXI BIO HKEx 216,907.105 188.686 188.685 15.1677 -
Local Peer SINO BIOPHARM HKEx 172,873.016 56.324 56.839 4.9897 0.580
Local Peer BEIGENE HKEx 149,335.384 - - 7.5969 -
Local Peer GENSCRIPT BIO HKEx 29,593.630 - - 9.9215 -
Local Peer 3SBIO HKEx 23,883.934 21.632 21.632 2.2183 -
Local Peer VIVA BIOTECH HKEx 19,401.459 64.356 64.355 9.7584 0.161
Local Peer HAOHAI BIOTEC HKEx 18,160.099 43.194 43.194 3.0875 0.750
Local Peer ALPHAMAB-B HKEx 14,972.779 - - 5.5177 -
Local Peer ASCENTAGE-B HKEx 8,228.398 - - 8.2608 -
Local Peer FRONTAGE HKEx 7,523.136 52.091 52.093 3.6489 -
Local Peer KINTOR PHARMA-B HKEx 5,681.218 - - 15.3692 -
Local Peer SINOMAB BIO-B HKEx 3,431.278 - - 2.7100 -
Other Local Peers LEE'S PHARM (HKEx), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), UNI-BIO GROUP (HKEx), CT ENTERPRISE (HKEx), BIOSINO BIO-TEC (HKEx), REGENT PACIFIC (HKEx), HAO WEN HLDGS (HKEx)
Global Peer AMGEN INC NASDAQ 140,835.979 17.959 19.295 13.2129 2.436
Global Peer CSL ASX 126,834.048 47.275 43.784 14.6656 0.950
Global Peer GILEAD SCIENCES INC NASDAQ 85,478.630 15.871 - 4.7417 3.732
Global Peer VERTEX PHARMACEUTICAL NASDAQ 69,583.759 59.129 33.441 9.2541 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 64,993.791 30.718 21.784 7.1758 -
Global Peer ILLUMINA INC NASDAQ 51,615.380 51.512 74.481 11.3117 -
Global Peer BIOGEN INC NASDAQ 45,679.633 7.757 7.707 4.0393 -
Global Peer SEATTLE GENETICS INC NASDAQ 27,863.880 - - 15.3598 -
Global Peer MODERNA INC NASDAQ 26,764.836 - - 9.0824 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,331.537 9.288 26.393 2.1287 -
Other Global Peers BIOMARIN PHARMACEUTICAL (NASDAQ), INCYTE CORPORATION (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NOVAVAX INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), EXELIXIS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), Lonza (SGX), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), FIBROGEN INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ALKERMES PLC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), INSMED INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), ALLOVIR INC (NASDAQ), VAXCYTE INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), KODIAK SCIENCES INC (NASDAQ), VIELA BIO INC (NASDAQ), VERACYTE INC (NASDAQ), XENCOR INC (NASDAQ), UNIQURE N.V. (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), AKEBIA THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), NANOSTRING TECHNOLOGIES INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), COMPUGEN (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), MESOBLAST LTD (ASX), COHERUS BIOSCIENCES INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), CORTEXYME INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ALECTOR INC (NASDAQ), ARVINAS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), POLYNOVO LIMITED (ASX), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), NANTKWEST INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), VAXART INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), NKARTA INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), OMEROS CORP (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PERSONALIS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), PRECIGEN INC (NASDAQ), KADMON HLDGS INC (NYSE), AKOUOS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), AGENUS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), IMMATICS N V (NASDAQ), VANDA PHARMACE INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), PROTAGONIST